ArticleOPEN ACCESS

Patient-derived sarcoma xenografts for individual-patient selection of chemotherapy - Ready for prime time?

Cancer
DOI: 10.1002/cncr.28694
4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Patient-derived sarcoma tumor xenografts can be successfully grown in mice and tested for sensitivity to chemotherapy regimens. Are these tests ready to guide patient care? © 2014 American Cancer Society.

Cite

CITATION STYLE

APA

Wagner, A. J. (2014, July 1). Patient-derived sarcoma xenografts for individual-patient selection of chemotherapy - Ready for prime time? Cancer. John Wiley and Sons Inc. https://doi.org/10.1002/cncr.28694

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free